Implementation of a patient blood management program in hematopoietic stem cell transplantation (Editorial, p. 2763).

ABSTRACT:

Background

Recipients of hematopoietic stem cell transplantation (HSCT) are among the highest consumers of allogeneic red blood cell (RBC) and platelet (PLT) components. The impact of patient blood management (PBM) efforts on HSCT recipients is poorly understood.

Study design and methods

This observational study assessed changes in blood product use and patient-centered outcomes before and after implementing a multidisciplinary PBM program for patients undergoing HSCT at a large academic medical center. The pre-PBM cohort was treated from January 1 through September 31, 2013; the post-PBM cohort was treated from January 1 through September 31, 2015.

Results

We identified 708 patients; 284 of 352 (80.7%) in the pre-PBM group and 225 of 356 (63.2%) in the post-PBM group

SUBMITTER: Warner MA 

PROVIDER: S-EPMC6813829 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature